Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01434862 · ClinicalTrials.gov registry record · NA
Pramlintide Combined With Model Predictive Control Algorithm
A NA study, sponsored by University of Virginia.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT01434862 is a NA study that was terminated before completion, run by University of Virginia. The registered enrollment target is 2 participants.
The verdict
NCT01434862, a NA study, was terminated before completion, sponsored by University of Virginia.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is a scientific research study that will look at how a "closed-loop" system and the drug Pramlintide may work together to improve blood sugar control in people with type 1 diabetes mellitus. Pramlintide is approved by the Food and Drug Administration (FDA) and is given as an injection (subcutaneous) that works with insulin to lower blood sugar.
Interventions
- DRUG Closed loop with pramlintide
- DEVICE Closed loop without pramlintide
- DRUG Open loop with pramlintide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-02 |
| Est. Completion | 2012-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01434862
The ClinicalTrials.gov registry entry for NCT01434862 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Closed loop with pramlintide is the first listed.
NCT01434862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01434862 about?
NCT01434862 is a clinical study titled "Pramlintide Combined With Model Predictive Control Algorithm". This is a scientific research study that will look at how a "closed-loop" system and the drug Pramlintide may work together to improve blood sugar control in people with type 1 diabetes mellitus. Pramlintide is approved by the Food and Drug Administration (FDA) and is given as an injection (subcutan...
What is the current status of trial NCT01434862?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2011-02. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01434862?
The interventions under investigation include: Closed loop with pramlintide (DRUG), Closed loop without pramlintide (DEVICE), Open loop with pramlintide (DRUG).
Who is sponsoring clinical trial NCT01434862?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.